XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net income (loss) $ 13,948 $ (2,677)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization expense 45,421 40,146
Equity in income of joint ventures (3,706) (3,858)
Stock-based compensation expense 6,968 5,070
Elimination of unrealized loss on sales to joint ventures 0 (741)
Changes in fair value of contingent consideration 0 398
Deferred taxes (12,934) (1,071)
Unrealized foreign exchange (gain) loss (1,209) 660
Changes in assets and liabilities:    
Accounts receivable, net 37,828 29,332
Inventories (5,026) (17,286)
Other assets (9,868) (7,629)
Accounts payable and accrued liabilities (38,370) (14,570)
Other liabilities 13,391 2,755
Income taxes, net (3,983) 1,391
Other (951) (1,982)
Net cash provided by operating activities 41,509 29,938
Cash flows from investing activities:    
Capital expenditures (33,112) (30,739)
Net cash used in investing activities (33,112) (30,739)
Cash flows from financing activities:    
(Cash pledged for) release of collateral deposits, net (415) 650
Proceeds from borrowings 0 21,204
Repurchase of common stock (10,020) 0
Payment of withholding taxes on stock-based compensation plans (2,588) (4,095)
Repayment of financed insurance premium (1,739) (2,327)
Repayments of finance leases (342) (541)
Net cash (used in) provided by financing activities (15,104) 14,891
Effect of exchange rate changes on cash and cash equivalents 2,218 (2,722)
Net (decrease) increase to cash and cash equivalents and restricted cash (4,489) 11,368
Cash and cash equivalents and restricted cash at beginning of period 184,663 153,166
Cash and cash equivalents and restricted cash at end of period $ 180,174 $ 164,534